Current Liabilities
Accounts Payable
Amgen Accounts Payable increased by 24.0% to $2.94B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.0%, from $2.41B to $2.94B. Over 5 years (FY 2020 to FY 2025), Accounts Payable shows an upward trend with a 10.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase may suggest improved cash flow management or delayed payments, while a decrease may indicate faster settlement of obligations or reduced purchasing activity.
Detailed definition
Accounts payable represents the total amount of short-term obligations owed to suppliers and vendors for goods or servic...
Peer comparison
Standard across all industries; peers in biotech typically maintain consistent ratios relative to cost of goods sold.
Metric ID:
accounts_payableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.28B | $1.17B | $1.37B | $1.40B | $1.26B | $1.20B | $1.57B | $1.32B | $1.21B | $1.36B | $1.59B | $1.63B | $2.27B | $2.15B | $1.91B | $2.41B | $3.01B | $2.84B | $2.37B | $2.94B |
| QoQ Change | — | -8.3% | +16.7% | +2.7% | -10.5% | -4.1% | +30.6% | -16.0% | -8.2% | +12.0% | +17.1% | +2.4% | +39.3% | -5.3% | -11.1% | +26.1% | +25.1% | -5.7% | -16.6% | +24.0% |
| YoY Change | — | — | — | — | -1.6% | +2.8% | +15.1% | -5.9% | -3.5% | +12.8% | +1.1% | +23.3% | +87.0% | +58.1% | +20.0% | +47.8% | +32.8% | +32.2% | +24.1% | +22.0% |
Range$1.17B – $3.01B
CAGR+19.1%
Avg YoY Growth+23.0%
Median YoY Growth+21.0%
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Amgen's accounts payable?
- Amgen (AMGN) reported accounts payable of $2.94B in Q1 2026.
- How has Amgen's accounts payable changed year-over-year?
- Amgen's accounts payable increased by 22.0% year-over-year, from $2.41B to $2.94B.
- What is the long-term trend for Amgen's accounts payable?
- Over 5 years (2020 to 2025), Amgen's accounts payable has grown at a 10.7% compound annual growth rate (CAGR), from $1.42B to $2.37B.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods and services purchased on credit.